Dawnrays Cefoperazone Sodium and Tazobactam Sodium for Injection (4:1) Package Insert

Package insert for Dawnrays cefoperazone sodium and tazobactam sodium for injection (4:1): indications, dosage, warnings, adverse reactions and storage.


Dawnrays Cefoperazone Sodium and Tazobactam Sodium for Injection (4:1) Package Insert - cover page
Brand
Dawnrays
Category
Drugs
Document type
User Manual
Language
Chinese
Pages
2
File format
PDF
File size
455 KB
Published
10 November, 2026
Updated
10 November, 2026
MD5 checksum
1E897521B6C33E4EEB2C8CA63B91C7CF

About this manual

Package insert for a compound injection containing cefoperazone sodium and tazobactam sodium in a 4:1 ratio, supplied as a white or off-white, hygroscopic crystalline powder in 1.0 g and 2.0 g strengths. It is indicated only for moderate to severe infections caused by beta-lactamase-producing bacteria that are resistant to cefoperazone alone and sensitive to the combination, including lower respiratory tract, urinary and genital tract, abdominal and pelvic infections, and sepsis and meningitis caused by the listed organisms.

The injection is given intravenously after dissolution and dilution, usually 2 g every 8 or 12 hours in adults, for a course generally of 7 to 10 days. The insert covers adverse reactions, contraindications, warnings about bleeding and coagulation disorders, use in pregnant and breastfeeding women, children and the elderly, drug interactions, overdose, pharmacology and toxicology, pharmacokinetics, storage, packaging, approval numbers and the marketing authorization holder, Dawnrays (苏州东瑞制药有限公司). This manual is written in Chinese.

What's inside

  • Indications
  • Strength
  • Dosage and Administration
  • Adverse Reactions
  • Contraindications
  • Precautions
  • Drug Interactions
  • Pharmacology and Toxicology
  • Pharmacokinetics
  • Storage and Packaging

Specifications

Strength (1.0 g)Cefoperazone 0.8 g and tazobactam 0.2 g
Strength (2.0 g)Cefoperazone 1.6 g and tazobactam 0.4 g
AppearanceWhite or off-white crystalline powder, hygroscopic
Shelf life24 months
StorageSealed, in a cool dark dry place, protected from light and not above 20 °C
Executive standardYBH01542019
Approval number (1.0 g)国药准字 H20193193

Frequently asked questions

How is this injection given?

The powder is first dissolved and diluted, then given by intravenous infusion; each infusion takes 30 to 60 minutes.

What is the recommended adult dose?

Adults receive 2 g by intravenous infusion every 8 or 12 hours, usually for 7 to 10 days.

How should the product be stored?

It should be kept sealed in a cool, dark and dry place, protected from light and at no more than 20 °C.

When is the product contraindicated?

It must not be used in patients allergic to any of its components or to other beta-lactam antibiotics.

Download PDF (455 KB)

More Dawnrays Manuals


View all Dawnrays manuals →